Home Microlin Bio buys Marina Biotech's nucleic acid therapeutics assets in cash-and-stock deal
 

Keywords :   


Microlin Bio buys Marina Biotech's nucleic acid therapeutics assets in cash-and-stock deal

2016-03-16 19:30:38| Biotech - Topix.net

Microlin Bio and Marina Biotech execute a term sheet under which Microlin intends to acquire Marina's nucleic acid therapeutics assets for 6.7M shares of Microlin stock and ~$1M in cash. Based on the recent price of $1.50 per share of MICB, the deal is valued at slightly more than $11M.

Tags: deal acid bio assets

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
29.04WasteNot Composts Liam Donnelly Dreams Big
29.04Delivery firm Getir to exit UK, Europe and US
29.04Recycling Works. If We Dont Counter the Naysayers, It Wont
29.04Kering Names New President and CEO
29.04Elina Organics Introduces Blemish-Fighting Roller
29.04Versed Skin Launches Third Hue in Mood Lighting Glow Drops
29.04Bread and biscuit prices could rise due to wet weather
29.04Columbia, Mo. Evaluates Options to Improve Recycling Facility
More »